0002084031 2026-09-15 2026-09-15 0002084031 1 2026-09-15 2026-09-15 0002084031 2 2026-09-15 2026-09-15 0002084031 3 2026-09-15 2026-09-15 iso4217:USD pure 0002084031 EX-FILING FEES S-1 S-1 N/A N/A RegenLab USA, Inc. Equity Common Stock, par value $0.001 per share false false false true 34500000.00 0.00013810 4764.45 Equity Warrants true -0 Equity Common Stock Underlying true 1293750.00 0.00013810 178.67 35793750.00 4943.12 0.00 0.00 4943.12 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify">(1)</td> <td style="text-align: justify">Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. Includes the offering price attributable to additional common stock that the underwriter has the option to purchase to cover over-allotments, if any.</td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify">(2)</td> <td style="text-align: justify">Pursuant to Rule 416 under the Securities Act, the securities being registered hereunder include such indeterminate number of additional common stock as may be issued after the date hereof as a result of share sub-divisions, share capitalization or similar transactions.</td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify">(3)</td> <td style="text-align: justify">Calculated pursuant to Rule 457(o) under the Securities Act, based on an estimate of the proposed maximum aggregate offering price.</td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify">(4)</td> <td style="text-align: justify">No fee required pursuant to Rule 457(g) under the Securities Act.</td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify">(5)</td> <td style="text-align: justify">Represents common stock underlying warrants issuable to the representative to purchase a number of common stock equal to 3% of the total number of common stock sold in this offering at an exercise price equal to 125% of the public offering price of the common stock sold in this offering.</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify">(1)</td> <td style="text-align: justify">Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. Includes the offering price attributable to additional common stock that the underwriter has the option to purchase to cover over-allotments, if any.</td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify">(2)</td> <td style="text-align: justify">Pursuant to Rule 416 under the Securities Act, the securities being registered hereunder include such indeterminate number of additional common stock as may be issued after the date hereof as a result of share sub-divisions, share capitalization or similar transactions.</td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify">(3)</td> <td style="text-align: justify">Calculated pursuant to Rule 457(o) under the Securities Act, based on an estimate of the proposed maximum aggregate offering price.</td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify">(4)</td> <td style="text-align: justify">No fee required pursuant to Rule 457(g) under the Securities Act.</td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify">(5)</td> <td style="text-align: justify">Represents common stock underlying warrants issuable to the representative to purchase a number of common stock equal to 3% of the total number of common stock sold in this offering at an exercise price equal to 125% of the public offering price of the common stock sold in this offering.</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify">(1)</td> <td style="text-align: justify">Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. Includes the offering price attributable to additional common stock that the underwriter has the option to purchase to cover over-allotments, if any.</td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify">(2)</td> <td style="text-align: justify">Pursuant to Rule 416 under the Securities Act, the securities being registered hereunder include such indeterminate number of additional common stock as may be issued after the date hereof as a result of share sub-divisions, share capitalization or similar transactions.</td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify">(3)</td> <td style="text-align: justify">Calculated pursuant to Rule 457(o) under the Securities Act, based on an estimate of the proposed maximum aggregate offering price.</td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify">(4)</td> <td style="text-align: justify">No fee required pursuant to Rule 457(g) under the Securities Act.</td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify">(5)</td> <td style="text-align: justify">Represents common stock underlying warrants issuable to the representative to purchase a number of common stock equal to 3% of the total number of common stock sold in this offering at an exercise price equal to 125% of the public offering price of the common stock sold in this offering.</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>